FUS and myeloid sarcoma: We therefore used immunohistochemistry to evaluate the distribution of p54nrb/NONO in the spinal cord of ALS-FUS patients compared with neurologically healthy controls, a case of multiple sclerosis (MS) and sporadic ALS (sALS) cases.